Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

486
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
486
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

752
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Social dysfunction and default mode network functional integrity in neuropsychiatric disorders: A cross-disorder replication and generalization study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same author

Neuropathological correlates of age and sex differences in 18F-flortaucipir PET.

Brain : a journal of neurology·2026
Same author

An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration.

Nature medicine·2026
Same authorSame journal

[The Clinical Applicability of Blood Biomarkers for Alzheimer's disease in the Memory Clinic].

Tijdschrift voor gerontologie en geriatrie·2026
Same author

[Periprosthetic femoral fractures: the orthopaedic disease of affluence?]

Nederlands tijdschrift voor geneeskunde·2026
Same author

Microglia protein profiles in CSF across Alzheimer's disease clinical stages.

Nature aging·2026
Same journal

Tijdschrift voor gerontologie en geriatrie·2026
Same journal

[Peer-advice for aging in place: An exploratory study on the perspectives of community-dwelling older adults].

Tijdschrift voor gerontologie en geriatrie·2026
Same journal

[Geriatric rehabilitation on Curacao].

Tijdschrift voor gerontologie en geriatrie·2025
Same journal

[Usability of activity trackers in geriatric rehabilitation].

Tijdschrift voor gerontologie en geriatrie·2025
Same journal

Tijdschrift voor gerontologie en geriatrie·2025
See all related articles

Related Experiment Video

Updated: Jan 8, 2026

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
08:07

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

Published on: November 23, 2019

11.7K

[Frontotemporal dementia in the elderly: Practical tools].

Niek Verwey1,2, Yolande Pijnenburg2,3, Floor Duits2,3

  • 1Geheugenpolikliniek, Medisch Centrum Leeuwarden, Leeuwarden.

Tijdschrift Voor Gerontologie En Geriatrie
|December 17, 2025
PubMed
Summary
This summary is machine-generated.

Frontotemporal dementia (FTD) is a rare cause of dementia in older adults. This article highlights two cases to improve awareness and timely diagnosis for better patient care.

Keywords:
AlzheimerAmloydBiomarkersDementiaPlasmaTau

More Related Videos

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.1K
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K

Related Experiment Videos

Last Updated: Jan 8, 2026

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
08:07

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

Published on: November 23, 2019

11.7K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.1K
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K

Area of Science:

  • Neurology
  • Geriatrics
  • Neuroscience

Background:

  • Frontotemporal dementia (FTD) typically affects younger individuals.
  • Diagnosis of FTD is challenging due to diverse symptoms often mistaken for other conditions.
  • FTD can occur in older adults, though it is rare.

Purpose of the Study:

  • To present two cases of FTD in older individuals.
  • To increase awareness of FTD in the elderly population.
  • To emphasize the importance of timely and accurate diagnosis.

Main Methods:

  • Case report presentation.
  • Review of clinical symptoms and diagnostic challenges.
  • Discussion of FTD in the context of geriatric cognitive impairment.

Main Results:

  • Two cases of FTD in older adults are detailed.
  • The complexity of diagnosing FTD in elderly patients is illustrated.
  • The potential for misattribution of symptoms to more common causes is highlighted.

Conclusions:

  • FTD is an important consideration in older adults with cognitive and behavioral changes.
  • Early and precise diagnosis of FTD is crucial for effective management.
  • Improved awareness can lead to better support for patients and families affected by FTD.